Brief: Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results

Zynerba Pharmaceuticals

10/08/2020 11:57

Aug 10 (Reuters) - Zynerba Pharmaceuticals Inc  ZYNE.O :
    * ZYNERBA PHARMACEUTICALS REPORTS SECOND QUARTER 2020
FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
    * Q2 LOSS PER SHARE $0.78
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.45 -- REFINITIV IBES
DATA
    * ZYNERBA PHARMACEUTICALS - RECRUITMENT INTO PHASE 2 INSPIRE
TRIAL
OF ZYGEL IN 22Q DELAYED DUE TO COVID-19 IMPACT IN AUSTRALIA
    * ZYNERBA PHARMACEUTICALS - BELIEVES CURRENT CASH,
EQUIVALENTS
SUFFICIENT TO FUND OPERATIONS, CAPITAL REQUIREMENTS INTO Q4 OF
2021

Source text for Eikon:  ID:nGNX2Jsj1R 
Further company coverage:  ZYNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))